Ignite Creation Date:
2025-12-24 @ 7:56 PM
Ignite Modification Date:
2025-12-25 @ 5:31 PM
Study NCT ID:
NCT00284804
Status:
COMPLETED
Last Update Posted:
2015-10-12
First Post:
2006-01-30
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-11
Start Date Type:
None
Primary Completion Date:
2008-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-10
Completion Date Type:
ACTUAL
First Submit Date:
2006-01-30
First Submit QC Date:
None
Study First Post Date:
2006-02-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-10-12
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-09-23
Last Update Post Date:
2015-10-12
Last Update Post Date Type:
ESTIMATED